SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001341004-16-001372
Filing Date
2016-04-29
Accepted
2016-04-29 16:24:35
Documents
3

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D, AMENDMENT NO. 1 sc13da1.htm SC 13D/A 93170
2 EXHIBIT 99.1 - NON-BINDING LETTER OF INTENT ex99-1.htm EX-99 58138
3 ferrer.jpg GRAPHIC 3928
  Complete submission text file 0001341004-16-001372.txt   158310
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Subject) CIK: 0001344413 (see all company filings)

IRS No.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82505 | Film No.: 161606969
SIC: 2834 Pharmaceutical Preparations

Mailing Address AVENIDA DIAGONAL 549, 5TH FLOOR BARCELONA U3 E-08029
Business Address AVENIDA DIAGONAL 549, 5TH FLOOR BARCELONA U3 E-08029 34-93-600-3716
Grupo Ferrer Internacional, S.A. (Filed by) CIK: 0001623398 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U3 | Fiscal Year End: 1231
Type: SC 13D/A